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Abstract
Introduction The most invalidating and life-threatening
complication in Hirschsprung’s disease patients (HSCR) is
Hirschsprung’s disease-associated enterocolitis (HAEC).
The mechanisms underlying enterocolitis have not been
identified. The limited knowledge of the role of intestinal
microflora is in part due to the complexity of the intestinal
microbiome and to the limitation of cultivation-based
technologies, given that less than 25% of the intestinal
bacterial species can be cultured.
Materials and methods We used amplified ribosomal
DNA restriction analysis (ARDRA) with four different
restriction enzymes to study variations of microflora
composition of the stools of a selected HSCR patient in
different clinical conditions (acute phase vs. remission).
Results We assessed a total of 15 stool specimens
belonging to the same 3-year-old male patient suffering
from HSCR, which were harvested during 4 HAEC epi-
sodes and remission phases. Restriction analysis showed
that HAEC episodes seem to cluster together at ARDRA
analysis, thus suggesting a sort of predisposing bacterial
community for HAEC development and the need for a
microflora equilibrium to maintain wellness.
Conclusions This approach proved to be effective, useful
and powerful in assessing microflora dynamics and indi-
cated that the differences in microflora associated with
acute HAEC or remission are likely to result from a
combination of disease activity and different antibiotic
therapies. ARDRA proved to be useful in discriminating
disease versus remission. Our findings indicated that
HAEC results from a change in the equilibrium between
bacterial species or from altered discrimination of harmless
from harmful microorganisms, challenging the definition of
pathogenic and non-pathogenic species. Based on these
results, we propose ARDRA as a rapid inexpensive tool to
assess microflora dynamics during HAEC episodes.
Keywords Hirschsprung  Enterocolitis  Microbioma 
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Introduction
Hirschsprung’s disease (HSCR) is a developmental disor-
der of the enteric nervous system characterized by the
congenital absence of parasympathetic intrinsic ganglion
cells in the submucosal and myenteric plexuses of the
hindgut with variable proximal extension. Clinical features
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of HSCR are heterogeneous: patients can experience neo-
natal intestinal obstruction, delayed meconium passage,
chronic constipation, abdominal distension and the most
debilitating and life-threatening complication, named
HSCR-associated enterocolitis (HAEC) [1–3]. HAEC is
defined as a clinical condition characterized by explosive
diarrhea, abdominal distension, fever and impending septic
shock [4].
HAEC can occur at any time starting from the neonatal
period and is often independent of surgical treatment,
though its severity seems higher before surgery [5]. The
incidence of HAEC ranges from 20 to 58% and its mor-
tality rate has significantly decreased over the past 20 years
from 30 to 1% due to early diagnosis, rectal decompres-
sion, appropriate vigorous resuscitation and antibiotic
therapy. However, a number of patients with HAEC need
an enterostomy (colostomy or ileostomy). Even though
several hypotheses have been formulated with regard to the
physiopathology of HAEC, the concurring mechanisms
underlying enterocolitis have not been identified yet. His-
tological and immunological studies suggest that some
patients are prone to recurrent HAEC due either to per-
sistent inflammation within the bowel or to immunodefi-
ciency/dysfunctions of cells of the immune system [6]. As
it has been observed for inflammatory bowel diseases
(IBD), the role of intestinal microflora is indeed of para-
mount importance in determining the onset and the gravity
of HAEC [7]. The intestinal immune system maintains
immunologic homeostasis against gut luminal antigens.
Alternatively, it also provides an appropriate immune
response against microbial pathogens at the local site of
inflammation [8–10]. Clostridium difficile and Rotavirus,
have been associated with HAEC, although the etiology is
extremely variable [11] and there are also reports of the
presence of different Candida species [12]. The limited
knowledge of the HAEC determinants is in part also due to
the complexity of the intestinal microbiome. One genomic
estimate of the biodiversity of intestinal microflora indi-
cated roughly 400 different phylotypes that can colonize
both intestinal lumen and mucosa, being less than 20%
cultivable [13]. The traditional methods based on culturing
bacteria require fresh material and considerable experi-
mental equipment for anaerobic culturing, which is difficult
to undertake in the field. However, culture-independent
methodologies based on the amplification of bacterial 16S
rRNA genes by polymerase chain reaction (PCR) require
only bacterial genomic DNA as templates. The 16S rDNA
region is universally considered a good marker to screen
and identify bacterial species due to the variability of this
region. To assess the structure of a particular micro-
bial community, the amplified ribosomal DNA can
be analyzed by amplified ribosomal DNA restriction
analysis (ARDRA), denaturing gradient gel electrophoresis
(DGGE) or temperature gradient gel electrophoresis
(TGGE) [14].
Many authors use 16S rDNA restriction analysis to
characterize bacterial species isolated from nature. The
vast majority of these studies are performed following
cultivation and isolation in pure culture of a bacterial
species. In a sizeable fraction of the cited literature, AR-
DRA was not performed directly on PCR-amplified
community DNA, but rather on clones from a library of
PCR-amplified DNA [15, 16]. In these types of experi-
ments, ARDRA is used to identify major groups of species
from among the clones by patterns of similarity in their
restriction fragments. Sequencing is then done on repre-
sentative clones from each ARDRA-defined group. In this
way, ARDRA is used as a shortcut to minimize sequencing
of clone libraries.
The aim of this study was to explore the potential of
ARDRA technique to assess changes in microbial com-
position of the stool of HSCR patients. In particular, we
aimed at assessing whether DNA-based technologies can
overcome the limitations derived from limited cultivability
of bacterial species.
Methods
Fresh stools were collected from a 3-year-old male patient
with an ultra-long form of HSCR (total colonic aganglio-
nosis, TCSA) during different enterocolitis and remission
episodes between June and October 2008 (Table 1). The
diagnosis of intestinal aganglionosis was obtained with
histochemistry on rectal suction biopsies according to
widely accepted criteria [1]. The diagnosis was confirmed
with intraoperative histochemistry and pathological anal-
ysis of the resected bowel. Enterocolitis was diagnosed
according to the criteria described by Pastor AC et al. in
2009 [29].
Furthermore, the patient’s DNA underwent molecular
analysis of RET proto-oncogene, as previously reported
[18, 19], without finding any mutation. Extensive geno-
typing of the same gene revealed a homozygous condition
for an SNP allele (RET ? 3_T allele), known to be a
predisposing factor for HSCR development [20].
Ethical approval
The Giannina Gaslini Institute Ethic Committee Board
approved this study as a part of a comprehensive research
on Hirschsprung’s disease-associated enterocolitis. A
detailed informed consent was obtained by the parents
before starting with this study.
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Collection of fecal samples and DNA extraction
Stool samples were kept at 4C until the analysis was
performed. After homogenization by vigorous shaking by
hand, a portion of the suspension was centrifuged (10,000g,
for 10 min at 4C) to collect pellets. The pellets were
subjected to the DNA extraction procedure according to
Zoetendal et al. [17].
16S rDNA PCR amplification
Universal primers (forward primer Bact8F, 50-AGAG
TTTGATCCTGGCTCAG-30 and a reverse primer
Bact1510, 50-CGGTTACCTTGTTACGACTT-30) were
used to amplify the bacterial 16S rDNA. PCRs were per-
formed with PlatinumTaq DNA polymerase (Invitrogen,
Milano, Italy).
Each 50 ml PCR mixture contained 20 mM Tris–HCl (pH
8.4), 50 mM KCl, 1.5 mM MgCl2, 0.25 mM each of
deoxynucleoside triphosphate (dNTP), 2.5 U Taq DNA
polymerase, 0.4 lM of each primer and 100 ng of genomic
bacterial DNA. The samples were amplified in a BIO-016, MJ
Research PCR machine using the following program: initial
denaturation at 94C for 2 min; 35 thermal cycles of 94C for
30 s, 60C for 30 s and 72C for 1 min; and final elongation
at 72C for 8 min. The size and amount of the PCR products
were confirmed by analyzing 5 ll samples by 1% agarose gel
(wt/vol) electrophoresis and ethidium bromide staining. All
samples were subjected to ARDRA analysis.
ARDRA technique
We did set up efficient bacterial genomic DNA extraction
techniques from stools to amplify 16S rDNA from all
samples using selected universal primers. We initially used
ten different restriction enzymes that were indicated as
diagnostic [21, 22] to digest one sample of amplification
pool of bacterial 16S rDNA according to the method of
Vaneechoutte et al. [23]. The pools of digested DNA were
analyzed and, based on the results, we selected four 4 bp
restriction enzymes (HaeIII, AluI, MspI, RsaI—Fermentas,
Cornaredo, Milan, Italy) that generated more diagnostic
restriction profiles, producing the greatest number of
restriction fragments in our samples (Fig. 1a, b, c, d).
As much as 10 ll of 16S rDNA PCR product was
digested with 5 U of the previously indicated restriction
enzymes for 3 h at 37C. The restriction fragments were
separated on a 2.5% agarose gel for 2 h at 80 V and
visualized using Image Quant 350 gel documentation sys-
tem (GE Healthcare, Amersham Biosciences Cologno
Monzese, Italy). A 123 bp ladder (Invitrogen, Milano,
Italy) was used as a DNA marker. By way of illustration, a
dendrogram, based on ARDRA patterns, was constructed
using the PHYLIP program (Phylogeny Interference
Package-version 3.6 Dept of Genome Sciences, University of
Washington, Seattle, http://evolution.genetics.washington.
edu/phylip/getme.html) with 1% tolerance (i.e. bands that
differ by about seven nucleotides or less are considered
identical) and taking only fragments from 80 to 1,000
Table 1 Summary of fecal
samples obtained from a single
3-year-old pediatric patient
affected by HSCR with
recurrent enterocolitis episodes
between June and October 2008
Antibiotic dose: metronidazole
200 mg per die; amoxicillin/
clavulanic acid, regular dose
(RD): 0.8 g/die for amoxicillin
and 0.114 g/die for clavulanic
acid
a Double dose (1.6 g/die for
amoxicillin and 0.228 g/die for
clavulanic acid)
Sample’s ID Enterocolitis phases Antibiotic treatment
Period 1
T0 Pre-enterocolitis 12 h after stopping amoxicillin/clavulanic acid (RD)
T1 Acute enterocolitis Metronidazole
T2 Partial remission Amoxicillin/clavulanic acid (RD)
T3 Partial remission Amoxicillin/clavulanic acid (RD)
T4 Remission Amoxicillin/clavulanic acid (RD)
Period 2
T5 Remission Amoxicillin/clavulanic acid (RD)
T6 Pre-enterocolitis Amoxicillin/clavulanic acid (RD)
T7 Acute enterocolitis Metronidazole
Period 3
T8 Remission Amoxicillin/clavulanic acid (RD)
T9 Pre-enterocolitis Amoxicillin/clavulanic acida
T10 Pre-remission Amoxicillin/clavulanic acida
T11 Pre-remission Amoxicillin/clavulanic acida
Period 4
T12 Acute enterocolitis Metronidazole
T13 Acute enterocolitis Metronidazole
T14 Partial remission Amoxicillin/clavulanic acida
T15 Remission Amoxicillin/clavulanic acida
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nucleotides into account with the same methodology used to
compare restriction patterns from single bacterial species
isolates [24].
Results
Patient clinical features and enterocolitis episodes
During the study period (see Table 1 for details), the
patient underwent prolonged and repetitive treatments
with oral amoxicillin/clavulanic acid at a dose of 40 mg/
kg per die for amoxicillin and 28.5 mg/kg per die for
clavulanic acid, to decontaminate the bowel and reduce
fecal output. The first event of enterocolitis occurred after
amoxicillin/clavulanic acid discontinuation (sample T0
was collected 12 h after antibiotic suspension), which was
attempted to re-establish a native and natural bacterial
flora by antibiotics cycling. The patient was then treated
with oral metronidazole at a dosage of 20 mg/kg per die,
but the child developed enterocolitis (T1). Further
remission was obtained on re-introducing amoxicillin/
clavulanic acid therapy (T2–T5). During the second epi-
sode of enterocolitis, the patient was administrated oral
metronidazole (200 mg/die), according to widely accepted
guidelines [4, 5], to treat a presumable anaerobic micro-
flora overgrowth (T6), but he worsened (T7). A long
remission phase (T8) was subsequently experienced after
metronidazole discontinuation. A third episode was
anticipated by a pre-enterocolitis phase (T9), which was
preventively treated by doubling the dose of amoxicillin/
clavulanic acid (T10–T11) avoiding a real enterocolitis
recurrence. A fourth enterocolitis episode occurred
(T12–T13), but also in this occasion metronidazole treat-
ment worsened clinical conditions. In this latter event,
remission was obtained by doubling the dose of amoxicillin/
clavulanic acid (T14–T15). All stool samples were initially
characterized by conventional microbiological approaches.
Cultivation-based techniques and immunohistochemical
techniques excluded the presence of pathogens such as
Salmonella, Shigella, Campylobacter and C. difficile.
Furthermore, those techniques were not able to discriminate
between enterocolitis or remission phases based on the
presence of characteristic cultivable bacteria (data not
shown).
Analysis of restriction profiles
The clustering of the 16S rDNA restriction profiles (Fig. 2)
on the mixed bacterial populations allowed discriminating
every sample as unique and, in particular, to assess sample
similarity according to a well-established methodology. In
particular, we could observe that the enterocolitis samples
corresponded to specific changes in microflora with the
onset of enterocolitis episodes.
The first enterocolitis episode (Fig. 2) showed coher-
ence in the order of the samples: the samples clustered
temporally together and the order was in accordance with
disease progression, from the pre-enterocolitis phase to
acute enterocolitis and remission. The first episode fol-
lowed suspension of antibiotic treatment with amoxicillin/
clavulanic acid. The pre-enterocolitis phase in this patient
represented the starting point of microbial dynamics that
developed during the following months, as it was different
from all the others and behaved like a ‘‘root’’ of a clus-
tering tree. The acute enterocolitis episodes named second
and third were closer to each other compared to the first
Fig. 1 Gel image of ARDRA analysis of bacterial 16S rDNA
retrieved from the feces of an HSCR patient in different phases of the
disease (HAEC vs. remission phase) using, respectively, HaeIII (a),
MspI (b), RsaI (c) and AluI (d). The sample’s IDs are reported on
Table 1. MW ladder 123 bp. The detection of the band was performed
automatically on the original image using the Image Quant 350 gel
documentation system (GE Healthcare, Amersham Biosciences) for
the hierarchical clustering analysis
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acute enterocolitis episode, in agreement with the use of
metronidazole before the onset of these events.
It is noteworthy that the microflora profiles in partial
(T3, T14) and total remission (T4, T15) were always more
similar than the enterocolitis ones and were associated with
specific antibiotic treatment. The remission in all cases was
associated with the suspension of metronidazole treatment
and the use of amoxicillin/clavulanic acid resolved the
issue. The effect of change in antibiotic regimen on the
microflora can be appreciated also in the short term:
the restriction profiles of sample T9 was different from that
of sample T10 and T11, following 6 and 12 h of doubling
the dose of amoxicillin/clavulanic acid, respectively. Some
of the strains isolated during enterocolitis or remission
phases were also analyzed using ARDRA on single colo-
nies than on the pool. The results obtained on cultivated
strains were not similar to those of the pools and the
analysis of pure cultures was not able to discriminate
enterocolitis from remission (data not shown).
Discussion
In Hirschsprung’s disease-associated enterocolitis, fecal
bacteria concentrations increase at different levels with
severity of disease. The alteration in number and locali-
zation of bacteria can be the result of colon resection. In
particular, the anal sphincter hypertone resulting from
resection and ileo-anal anastomosis in long-segment HSCR
can cause retention and overgrowth of bacterial intestinal
biomass, both in the lumen and deep within the mucosa
(entero-adherent bacteria). In patients who underwent
resection of the ileo-cecal valve, a number of bacterial
species typically present in the colon can be found also in
the ileum. It is possible, therefore, to hypothesize a path-
ogenic role of the normal flora as a result of disruption of
components in the immune system or lack of proper
training of the immune systems cells in the Peyer’s pat-
ches, an organ of which tyrosine kinase receptor RET is a
key regulator [25].
Despite the recent advances in HSCR treatment, the
precise role of intestinal bacteria remains elusive. So far,
all the cultivation-based studies investigating bacterial
composition of HSCR patients have been hampered by the
fact that less than 30% of total microflora can be cultured.
Studies in healthy subjects based on the analysis of 16S
rRNA gene have been able to characterize approximately
90% of the dominant fecal microflora [26]. ARDRA of 16S
rDNA is commonly used to identify major groups of bac-
terial species. In this study, we evaluated the applicability
of ARDRA analysis on DNA extracted directly from fresh
feces in HSCR patients with enterocolitis and whether the
results reflect the variation in composition of bacterial
species associated with enterocolitis.
We demonstrated the utility and power of ARDRA
analysis on pools of genomic DNA extracted from stools in
assessing microflora dynamics, indicating that the differ-
ences in the microflora associated with disease and
remission in this specific case are likely to result from
different antibiotic therapies. Our findings indicate that
rather than due to the appearance of a specific bacterial
pathogen, enterocolitis seems to result from a change in the
equilibrium between bacterial species as shown in hierar-
chical clustering analysis of the ARDRA band profiles
(Fig. 2). The fact that two of the three samples of the same
episode, e.g. T6 and T7, cluster together while the third
(T8) clusters apart indicates that the clustering is driven by
drastic changes in the microbial pattern induced by the
change in antibiotic regimen, rather than time. The onset of
enterocolitis is clearly associated with a similar pattern of
microbial species as explained by the observation that pre-
enterocolitis sample T9 clusters close to acute enterocolitis
T7 and pre-enterocolitis T6, while remission of the first
episode T8 clusters close to antibiotic-associated pre-
remission of another episode, T10 and T11. The inability to
capture transient changes suggest that the coarseness of the
sampling is not fine enough. Additional time points, in
particular in the transition stage, would be needed to cap-
ture the details of a rapid transition in the composition of
the microbial communities.
Fig. 2 Dendrogram obtained from hierarchical clustering analysis of
the ARDRA band profiles. The calculation was performed using the
PHYLIP (Phylogeny Interference Package, version 3.6 Dept of
Genome Sciences, University of Washington, Seattle, http://evolution.
genetics.washington.edu/phylip/getme.html). The sample’s ID
(T0–T15) are summarized in Table 1
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Additionally, we showed that the differences between
enterocolitis and remission cannot be appreciated using
cultivation techniques and isolation in pure culture. The
concept of condition-dependent pathogenic role of micro-
flora, studied mainly in Crohn’s disease, has been termed
dysbiosis [27] and could probably be generalized also to
HSCR with enterocolitis.
The technology used does not identify the culprit, but
indeed can discriminate the restriction profile associated
with the disease. Recently, Palmer et al. [28] developed a
gut-specific DNA microarray containing 8,681 sequences
of 16S rDNA representing 359 different species of bacteria,
Archea and Eucharia. In particular, they tested and opti-
mized a DNA oligonucleotide microarray composed of
10.462 small subunit (SSU) ribosomal DNA (rDNA)
probes (8,681 unique sequences) selected to provide
quantitative information on the taxonomic composition of
diverse microbial populations. The authors affirmed that
the estimates of bacterial species abundance obtained using
this microarray are similar to those obtained by phyloge-
netic analysis of SSU rDNA sequences from the same
samples, which is considered the ‘‘gold standard’’ method
for profiling microbial communities. The limitation of
these techniques is that these are time consuming and
expensive, in particular requiring highly sophisticated and
intensive bioinformatics analyses. It is therefore extremely
important to select the most informative samples for these
highly sophisticated analyses. These results show the
potential of ARDRA as a rapid inexpensive tool to assess
variations in the microflora dynamics during HAEC epi-
sodes. Understanding the actual determinants of HAEC
will require the application of sequence-based metage-
nomic approaches enabling identification of species asso-
ciated with health and disease, in a much larger number of
HAEC patients. In this perspective, ARDRA could be
useful in screening large numbers of samples to select the
most informative one for further 16S rDNA sequencing
analysis.
Conclusion
We demonstrated that ARDRA is a rapid and inexpensive
tool to follow microflora dynamics during Hirschsprung’s
enterocolitis. Enterocolitis in this patient proved to be
dependent on the type of antibiotic treatment with sub-
sequent alteration of the microbial equilibrium resulting in
a change in the overall species composition. The unbalance
can be recovered by high doses of antibiotic therapy. The
conclusions drawn derive from a mixed sample, but iden-
tifying the bacterial species associated with the enteroco-
litis is beyond the scope of this experiment. Yet, the
monitoring of the microflora allows discriminating the
different samples and following the enterocolitis in a
dynamic way. ARDRA can be used to select the most
informative samples for more detailed analyses and also as
a monitoring approach to assess the probability of onset of
enterocolitis and the efficacy of a specific antibiotic
regimen.
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